SCHEMBL21844861

SCHEMBL21844861

Cc1ccc(NC(O)c2cccc(S(=O)(=O)N(CCO)C3CC3)c2)cc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 5/20 0.38
▸ PSEN2 P49810 5/20 0.38
▸ SPPL2A Q8TCT8 5/20 0.38
▸ APH1B Q8WW43 5/20 0.38
▸ NCSTN Q92542 5/20 0.38
▸ APH1A Q96BI3 5/20 0.38
▸ PSENEN Q9NZ42 5/20 0.38
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ PKM P14618 2/20 0.33
▸ MAPT P10636 3/20 0.33
▸ RECQL P46063 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CACNA1B Q00975 1/20 0.33
▸ CACNA1C Q13936 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20083990 0.79 LMNA (0.49) MEN1KMT2AMAPTRECQLTP53
SCHEMBL15276910 0.71 HTR2B (0.56) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL21844860 0.71 SMN1; SMN2 (0.58) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL18948579 0.70 KMT2A (0.40) MEN1KMT2AMAPTRECQLKDM4E
SCHEMBL15276906 0.69 SIRT2 (0.52) MEN1KMT2APKMMAPTSMN1; SMN2
SCHEMBL21844939 0.65 ALDH1A1 (0.40) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL15276909 0.65 RAB9A (0.50) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL15276907 0.65 SLC6A9 (0.46) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL15276904 0.64 MAPT (0.52) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL700255 0.64 CCR1 (0.39) ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback